The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Filtration - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...

US & Canada, April 24, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from ... the pharmaceutical industry records 6% growth year-on-year. The global burden of diseases such ...

Stagnation is not an option in the pharma world today. The companies that are anticipating these changes will be leaders, and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The report offers a detailed examination of industry trends and developments shaping the ... These organizations aim to remain competitive in the global pharmaceutical market while meeting regulatory ...

Johnson & Johnson is a global leader in the pharmaceutical ... Hellweg says Gilead is a market leader in both HIV and oncology. He says lenacapavir could potentially be a twice-yearly injectable ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

The report analyzes the Pharmaceutical Filtration market, presented in terms ... drawing insights from leading global economists and over 200 industry and policy institutions, including think ...